OA

Operose Advisors Portfolio holdings

AUM $517M Turnover 40.26%
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
-12.99%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$2.53M
Cap. Flow
+$18M
Cap. Flow %
12.64%
Top 10 Hldgs %
72.81%
Holding
326
New
7
Increased
35
Reduced
12
Closed
24
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.83%
2 Financials 4.02%
3 Technology 3.47%
4 Healthcare 1.47%
5 Consumer Discretionary 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACWI icon
276
iShares MSCI ACWI ETF
ACWI
$32.8B
$3K ﹤0.01%
30
– –
2021 Q4
2 quarters
CTAS icon
277
Cintas
CTAS
$82.8B
$3K ﹤0.01%
36
– –
2021 Q4
2 quarters
EFAD icon
278
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$62.4M
$3K ﹤0.01%
74
– –
2021 Q4
2 quarters
USMV icon
279
iShares MSCI USA Min Vol Factor ETF
USMV
$23.8B
$3K ﹤0.01%
39
– –
2021 Q4
2 quarters
WBD icon
280
DELISTED
Warner Bros
WBD
$3K ﹤0.01%
+196
New +$3.64K
2022 Q2
0 quarters
CI icon
281
Cigna
CI
$76.5B
$2K ﹤0.01%
9
– –
2021 Q4
2 quarters
DBC icon
282
Invesco DB Commodity Index Tracking Fund
DBC
$1.97B
$2K ﹤0.01%
79
– –
2021 Q4
2 quarters
EFAV icon
283
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.32B
$2K ﹤0.01%
36
– –
2021 Q4
2 quarters
VOO icon
284
Vanguard S&P 500 ETF
VOO
$1.04T
$2K ﹤0.01%
5
– –
2021 Q4
2 quarters
AEE icon
285
Ameren
AEE
$29B
$1K ﹤0.01%
5
– –
2021 Q4
2 quarters
AMC icon
286
AMC Entertainment Holdings
AMC
$2.58B
$1K ﹤0.01%
4
– –
2021 Q4
2 quarters
AVNS icon
287
DELISTED
Avanos Medical
AVNS
$1K ﹤0.01%
20
– –
2021 Q4
2 quarters
BHF icon
288
Brighthouse Financial
BHF
$2.75B
$1K ﹤0.01%
15
– –
2022 Q1
1 quarter
GE icon
289
GE Aerospace
GE
$319B
$1K ﹤0.01%
19
– –
2021 Q4
2 quarters
MCS icon
290
Marcus Corp
MCS
$873M
$1K ﹤0.01%
69
– –
2021 Q4
2 quarters
NKE icon
291
Nike
NKE
$52.4B
$1K ﹤0.01%
7
– –
2021 Q4
2 quarters
OXY.WS icon
292
Occidental Petroleum Corp Warrants
OXY.WS
$37.1B
$1K ﹤0.01%
25
– –
2021 Q4
2 quarters
SO icon
293
Southern Company
SO
$103B
$1K ﹤0.01%
20
– –
2021 Q4
2 quarters
UAL icon
294
United Airlines
UAL
$32.1B
$1K ﹤0.01%
13
– –
2021 Q4
2 quarters
VTRS icon
295
Viatris
VTRS
$20B
$1K ﹤0.01%
33
– –
2021 Q4
2 quarters
JO
296
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
$1K ﹤0.01%
25
– –
2021 Q4
2 quarters
CO
297
DELISTED
Global Cord Blood Corporation
CO
$1K ﹤0.01%
200
– –
2021 Q4
2 quarters
ABM icon
298
ABM Industries
ABM
$2.97B
– –
-896
Closed -$41K –
ANGO icon
299
AngioDynamics
ANGO
$465M
– –
-397
Closed -$9K –
BALL icon
300
Ball Corp
BALL
$16B
– –
-75
Closed -$7K –

Similar funds

Operose Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Operose Advisors held 326 positions worth $142M, down 1.7% from $145M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Operose Advisors deployed $18M of net new capital in Q2 2022, opening 7 new positions and adding to 35 existing holdings. Its largest new stake was Coinbase: 2,000 shares worth $94K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 85% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares MSCI Global Min Vol Factor ETF, an estimated $585K trimmed.

  • Operose Advisors's largest Q2 2022 buy was Coinbase: 2,000 shares worth $94K.
  • Operose Advisors added most to Vanguard High Dividend Yield ETF in Q2 2022, an estimated $7.05M increase.
  • Operose Advisors's biggest Q2 2022 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $585K.
  • Operose Advisors fully exited Nuveen ESG Small-Cap ETF in Q2 2022, selling an estimated $485K.
  • Operose Advisors's ten largest holdings make up 73% of its $142M portfolio in Q2 2022.
  • Operose Advisors opened 7 new positions and closed 24 in Q2 2022.
  • Operose Advisors's portfolio value fell 1.7% quarter-over-quarter to $142M.

Based on Operose Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.